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A COMPARATIVE STUDY OF CANINE AND HUMAN DERMATOLOGY
II. CUTANEOUS TUMORS—THE MAST CELL AND CANINE MASTOCYTOMA*
MILTON ORKIN, M.D.f AND ROBERT M. SCHWARTZMAN, V.M.D., M.P.ll.t
In a previous report (1) we discussed the im-
portance of comparative studies; reviewed basic
comparative (dog to man) anatomy, physiology
and reaction patterns; and delineated several
interesting dermatologic entities of canines,
including mastocytoma (in this paper mastocy-
toma will be represented by the initials MCT).
The increasing awareness of the mast cell in
health and disease and the ready availability of
canines with mast cell tumors has prompted the
authors to study intensively 13 cases of canine
MCT and investigate the comparative aspects.
Nickel (2) has recently presented a comprehen-
sive study of urticaria pigmentosa (mastocytosis,
human mast cell disease). Because of the exten-
sive bibliography included in the latter report,
only salient references will be listed in the present
study.
Many case presentations and discussions of
various facets of urticaria pigmentosa emphasize
the systemic ramifications. Since MCT of dogs
has systemic potential from its onset we may well
ask:
1. Is mast cell disease in dog and man related
(aside from the obvious fact of mast ccli involve-
ment in both)?
2. If they are related, then what information
can be obtained from their comparative study?
MAST CELL
Michels (3) devotes 119 pages in Downey's
Handbook of Hematology to discussion of the mast
cell. Only those segments which are germaine to
the present topic will he presented. Mast cells are
of histogenous origin. Their supply in a normal
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adult is maintained by homoplastic and hetero-
plastic regeneration; the former accomplished by
mitotic division of pre-existing mast cells and the
latter by elaboration of mast granules in various
connective tissue cells (lymphocytes, plasma cells,
clasmatoeytes, adventitial cells, endothelial cells
and possibly reticuloendothelial cells).
Michels further states that tissue mast cells
occur in all areas of the mammalian body, though
there may be quantitative differences between
species. Their numbers are proportional to the
amount of connective tissue present. Parenchyma-
tous organs such as the kidneys, adrenal and liver
have little connective tissue and therefore few
mast cells are present. The canine liver is an ex-
ception. Nielsen and Cole (4) emphasize their fre-
quency around small blood vessels in canine skin
and liver. The amount of connective tissue, and
therefore the number of mast cells, is greater in
the testis, ovary, salivary glands, heart, pancreas,
lymph nodes and spleen. In the tonsils, spleen and
lymph nodes many mast cells are present in the
capsule, adventitia of the large vessels, trabeculae
and medullary strands. Not infrequently mast
cells lie free in the lymph sinuses but apparently
never in the efferent lymphatics. Mast cells are
numerous in the serous membranes, pars nervosa
of the hypophysis, various layers of the digestive
and respiratory tracts and organs which have a
large amount of connective tissue (tongue, lung,
omentum, subcutaneous and intermuscular con-
nective tissue, etc.). Mast cells are fairly abun-
dant in the normal bone marrow of mammals.
Cartilage and bone (except for the periosteum and
perichondrium) are the only tissues devoid of
mast cells.
Lever (5) states that in man the relatively few
mast cells in the normal skin are spindle-shaped
and grouped around blood vessels and hair folli-
cles, and in the papillary layer of the dermis.
Johnson (6), however, writes that "the normal
human skin has somewhere between 2000 and 7500
mast cells per cubic millimeter depending on the
area from which it is taken." In the normal skin
of thy dog mast cells are abundant, patticularly
around small blood vessels. Their cell outline is
pleomorphic (fusiform, spherical, and stellate),
the nucleus round or ovoid (never lobulated) and
the cytoplasm abundant and filled with coarse
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granules denoting maturity. The same cell mor-
phology pertains in those conditions in the canine
in which there is benign proliferation of mast cells
(dermatitis, etc.).
There is evidence in both species that the mast
cell cytoplasm contains histamine, heparin and
hyaluronic acid in its metachromatic granules.
Despite the heparin content macroscopic hemor-
rhage concomitant with MCT is rare, although
Larson (7) reports severe post-excision hemor-
rhage in a significant number of cases (though only
a slight increase in the coagulation time).
West and Parratt (8) state that there is no
parallelism between the concentration of mast
cells and 5-hydroxytryptamine (serotonin) in the
skin of the guinea pig, rabbit, man, cat, mouse,
hamster and dog, despite previous reports to the
contrary. They further uphold that even in condi-
tions of mast cell proliferation (MCT of dogs, and
urticaria pigmentosa of man) there is no appre-
ciable increase in skin 5-hydroxytryptamine.
The tendency for mast cells to occur in densely
packed clusters is augmented under pathologic
conditions. Lever states that an increased number
of mast cells accompanies granulation tissue, most
itching dermatoses (atopic eczema, contact der-
matitis and lichen planus, etc.), neurofibromas,
the stroma of cutaneous carcinoma, urticaria pig-
mentosa and lupus erythematosus. In the latter,
the number of mast cells closely parallels the in-
tensity of metachromatic staining. Michels states
that mast cells are decreased during acute inflam-
mation, absent in scar tissue and markedly in-
creased in chronic inflammation and lymph
stagnation. The authors have observed an
increased number of mast cells in acute and
chronic canine dermatitis (Fig. 1).
CANINE MASTOCvTOMA
Mast cell tumors are frequent in dogs and rare
in other species. Of 1000 canine neoplasms col-
lated by Mulligan (9), 201 were sarcomas, 87 of
which were of mast cell origin. The MCT consti-
tutes 10 to 13.2% of all canine tumors. Bloom
(10) was the first to give a detailed pathologic
description of this condition (Table I). Nielsen
and Cole (4) present 100 cases (including 8 autop-
sies) collected over an 8-year period.
This condition shows a predilection for Boston
Terriers (over 40% of all neoplasms in this breed),
Boxers (over 30% of neoplasms) and Fox Ter-
riers (9% of all neoplasms) . The incidence of
MCT increases uniformly with age, the majority
of the subjects being six years or older. There is
no sex predilection.
The hindquarters (particularly the thigh)
Fin. 1. Typical mast cell as seen in normal canine skin; increased numbers in dermatitis. Toluidine
blue; X 720.
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scrotum and vulva are frequent sites of occur-
rence. Mulligan states that 40% of the tumors
occur on the scrotum, abdomen, axilla and eyelid;
30% on the posterior extremities; 20% on the
vulva, perineum, anterior extremities, thorax and
neck; and the remainder on the ear, mammary
gland, lip, penile sheath and mesenteric and
mediastinal connective tissues. The present
authors could find no other report of the occur-
rence of a primary MCT in an extracutaneous
location.
Clinically a lesion may be noted for one to two
years prior to examination; then grow rapidly in
a few months to significant size. The growth
originates as a small dermal mass which gradually
infiltrates the epidermis and the loose connective
tissue of the subcutis, but has little tendency to
involve the deeper fascia and muscles (11).
In Bloom's initial report (10), he presents 3
cases of solitary (benign?) and 2 of multiple
(apparently malignant?) MCT. He assumes that
the neoplastic cells result from a proliferation of
tissue mast cells (homoplastic regeneration). In
the process the cells become more uniform (oval
or spherical) and acquire a large vesicular nucleus.
He describes intracytoplasmic bodies which have
not been mentioned in subsequent literature or
observed in our own material.
Mulligan divides the MCT into mature and
anaplastic varieties. In the mature type mast cells
are discrete and polyhedral and their cytoplasm
pale, aeidophilie and sometimes vacuolated. The
nuclei are round or slightly oval, centrally placed,
and have a fine chromatin network bordered by a
heavy perinuclear membrane. Mitotic figures are
infrequent. The cells of the anaplastic type have
indistinct borders and unevenly enlarged nuclei
with irregular mitotic figures. Occasional multi-
nucleated forms are observed.
Nielsen and Cole (4) state that eosinophils are
common in MCT. In addition they note hi-
nucleated and trinueleated giant cells, somewhat
similar to Reed-Sternberg cells in 3% of their
cases. At times the latter together with immature
cells, many eosinophils, necrosis and fibrosis sug-
gest human Hodgkin's disease. Only the meta-
chromatic stain could definitely separate these
conditions. These authors further point out that
there are areas of MCT which contain no stain-
able granules. In general mast cell hyperplasia
(in dermatitis etc.) and slow growing MCT have
an abundance of mature cells with coarse, deeply-
stained granules in their cytoplasm. Rapidly
growing tumors contain immature cells with tiny
dust-like cytoplasmic granules, a few large
granules or no granules.
Paff and co-authors (12) in studying the be-
havior of neoplastic mast cells in tissue culture,
note spontaneous ameboid movements, amitotic
cell division and multinueleated cells. Oliver and
co-authors (13) show that the heparin content of
the MCT varies with the degree of anaplasia;
the mature tumor containing 50 times and the
immature 1.7 times the concentration of the
normal dog liver.
There are multiple opinions as to the causal
nature of the MCT. Hangartner (14) considers
them to be infectious granulomata while Bloom
(10) states that single tumors are benign and
multiple tumors generally malignant. Nielsen (11)
believes that all tumors (single or multiple) may
be sareomatous.
Involvement in the regional lymph nodes (26%
in Nielsen and Cole's (4) series), spleen and liver
is common in MCT. The general health of the
dog usually is not affected except in the terminal
stages where anemia, cachexia and other signs
may be manifest.
Nielsen and Cole (4) point that it is difficult
to differentiate between hyperplasia and neo-
plasia since transitional forms are well known.
They state that the cardinal criterion for malig-
nancy is a growth which will kill the host by
invasion and/or metastasis. This criterion cannot
be satisfied frequently in the canine, because dogs
are commonly euthanized before reaching a
terminal state. They believe that many eases of
MCT possess the following features of a sarcoma:
1. rapid infiltrating growth of immature cells;
2. recurrence after surgical removal often asso-
ciated with rapid invasion of the sur-
rounding tissues;
3. metastases to regional lymph nodes or
internal organs.
The therapy of choice for the small MCT is
surgical excision. Adrenaleortieal hormones pro-
duce a marked reduction in the number of normal
mast cells. Bloom (15), utilizing this knowledge,
treated a ease of recurrent multiple MCT with
cortisone (900 mg. over a 9-day period). After 3
days of therapy there was a sudden reduction in
the size of the lesions. Microscopic examination
revealed an ample number of mast cells with
cytoplasmic vacuolation and clumping of gran-
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ules. By the ninth day the nodules had completely
disappeared; histopathologie examination re-
vealed almost complete absence of mast cells,
with those present undergoing degeneration. Six
weeks later, however, a new nodule appeared at a
distant site and inguinal nodes were enlarged.
The pathologic changes in the mast cell in
Bloom's study were the same as those observed
by Asboe-Hanson (16) in independent study.
The benefits of cortisone therapy in MCT were
not verified by Larson (7).
Urbach and co-authors (17) used desoxycorti-
costerone (DOCA) in the treatment of 7 patients
with urticaria pigmentosa. In one, a 54-year old
white woman, a decrease in whealing was noted
in 2—3 months and a flattening of the lesions in
6 months. Some degree of relapse was noted three
months after discontinuing therapy.
METHODS AND MATERIALS
One hundred dogs with cutaneous tumors were
studied over a one-year period (May 1957 to
May 1958). Seventy-six canines were examined at
the University of Minnesota Veterinary Clinic.
In an additional 24 cases tumor tissue, together
with clinical data, were submitted by veterinarians
in the surrounding area. A majority of the cases
of the Veterinary Clinic were presented because
of cutaneous tumor(s); the remaining cases were
discovered during examination for some other
condition. Thirteen per cent of these tumors were
of mast cell origin. The other tumors will be the
subject of a subsequent communication.
Complete physical examination was done on
all the clinic animals. A punch or excision biopsy
was performed on one or more tumors in each of
the dogs. Touch smears and bleeding and clotting
time were determined in those cases in which
MCT was suspected.
Punch Biopsy—Hair was removed with a scis-
sors and the site anesthesized with Frigadcrm.®
A punch biopsy was performed in the usual
manner and the tissue fixed in 10% buffered For-
malin for at least 24 hours. Hcmatoxylin-eosin
and toluidine blue stains were performed in the
usual manner on all tumors.
Excision Biopsy—This was performed under
general anesthesia (pcntobarbital sodium) and the
tissue fixed and stained as above.
Touch Smears—A dry, clean slide was pressed
gently against the fresh cut surface of the excised
tumor. The slide was allowed to dry and stained
®BrachvogelHovey, Los Angeles, California.
with Wright's stain. Purple-red granules in cells
8—18 in diameter were considered diagnostic of
mast cells.
The authors obtained clinical data and tissue
in 7 cases of urticaria pigmentosa from the
Division of Dermatology for comparison with
the biopsy findings and clinical data of MCT.
RESULTS
A. Clinical Study of MCT (See Table II)
1. Age—14 weeks to 14 years; average 7.9
years.
2. Breed: Boston Terriers—4 (30%); Ter-
riers—3 (23%); Dachshund—2 (15%);
Boxer, Black Laborador, Chesapeake,
and English Setter, 1 each.
3. Sex—S female (62%) and 5 male (38%).
4. Duration before seen by veterinarian:
1—19 months; Average: 6.3 months.
5. Location of primary lesion—posterior
extremities—4 (30%); scapular region—3
(23%); groin and scrotum—2 (15%);
trunk—2 (15%); lower lip—i (7.7%)
and forearm—i (7.7%).
6. Clinical features (Fig. 2, 3)—the last 3
cases in Table II were submitted without
complete description and, therefore, will
not be included in some of the statistics.
a. Surface—yellow or white; ulcerated—
3 (30%); alopecia—4 (40%).
b. Size (diameter)—0.5 to 15 cm.; aver-
age 4.7 cm.
c. Form—firm, raised, papular-nodular—
4 (40%), cystic—2 (20%); fixed to
skin and free below.
7. Clinical diagnosis—correct in 4 (30%);
incorrect in 9 (70%); misdiagnosed as
reticulum cell sarcoma, lipoma, fibrosar-
coma, etc.
8. Number of tumors—3 cases (23%) with
multiple tumors.
9. Physical examination—lymphadenopathy
(Fig. 4)—3 (23%).
10. ilematologic data (4 cases)—no abnormal
bleeding or clotting time found.
11. Bone survey (2 cases—Case 10 showed
a discrete cystic area of rarefaction of the
ischium (Fig. 5).
12. Touch smears (4 cases)—positive in all
cases performed (Fig. 6).
13. Pathology—typical in S (62%); atypical
inS (38%).
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14. Treatment—excision.
15. Course (complication)—recurrence in 1
(7.7%); new lesion—2 (15%); 1 case
euthanized (autopsy permission denied).
B. Histopathologic Findings
1. Typical (Fig. 7,8)
a. Cytology—8-18
variable (usually
outline distinct cells look like frag-
ments of a mosaic; in some area cells
separated by clear spaces. Cytoplasm
—eosinophilic (at times red-purple),
some areas vacuolated; granules not
seen without special stain. Nucleus
—5 to 10 /2 diameter, large, vesicu-
lar, basophilic, centrally located; out-
line variable (usually round or oval,
C-shaped, reniform); occasionally hi-
nucleate; nucleoli—(none, 1 or 2); oc-
casional mitotic figures.
b. Architecture—Epidermis—One-third of
cases ulcerated with subjacent necrosis,
polymorphonuclear and fibrotic re-
sponse; if intact regular acanthosis.
Corium—Tumor usually fills corium;
no grenz zone; tumor cells push aside
connective tissue (some remaining
strands surround linear arrangement of
tumor cells); some areas simulate he-
patic parenchyma; tumor sharply out-
lines appendages and blood vessels (Fig.
9) but in no instance invades these
structures; numerous eosinophils (fig.
10) were scattered among the tumor
cells; occasional hemorrhage observed.
c. Toluidine blue stain—red-purple gran-
ules vary in size and intensity of
staining; usually fill cytoplasm, if
diffuse obscure cell detail.
2. Atypical—(frequently diagnosed as retic-
Fin. 3. Multiple lesions knee (MCT).
diameter; outline
polygonal), when
Fm. 2. Single lesion lower lip (MCT).
Mt
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FIG. 4. Popliteal lymph node (case 8). Numerous mast cells disrupt architecture. Toluidine blue;
X 75.
FIG. 5.
(case 10).
Cystic area of rarefaction of ischium
ulum cell lymphoma until special
stains done).
a. Gytology—anisoeytosis (fig. 11). Cyto -
plasm—lesser amount, foamy appear-
ance. Nucleus—more frequent mitotie
figures, multinueleated giant cells.
(One ease suggests Hodgkin's disease.)
b. Architecture—no marked difference
from the typical variety; eosinophils
present.
c. Toluidine blue stain—less positive,
smaller granules; some areas have no
granules (fig. 12).
). Comparative Study—7 eases of urticaria
pigmentosa in humans.
1. Age—S months to 24 years; average 4.5
years.
2. Sex—female 5 (71%); male—2 (29%).
3. Clinical—maeule dominant lesion in 4
(57%), nodule dominant in 3 (43%) eases.
There was no evidence of systemic in-
volvement (skeletal survey done in 2 pa-
tients). All lesions urtieated on stroking
(Darier's sign). None of the dogs with
MCT had a positive Darier's sign.
4. Histopathology
a. The findings in the maeular type
corresponded to Lever's description
(majority of cells spindle-shaped re-
sembling fibroblasts); these cells were
indistinguishable from normal canine
mast cells as described by Bloom (10)
4.
—
ii
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Fm. 6. Touch smear of MCT nodule. Wright's stain; X 720
Fin. 7. Typical MCT. llematoxylin-eosin; X 720
S
—
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FIG. 8. Typical MCT. Toluidine blue; X 720
FIG. 9. Typical MCT; tumor cells outline appendages but do not invade them. Toluidine blue; X 330
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FIG. 10. Typical MCT; numerous eosinophils scattered among tumor cells. Hematoxylin-eosin; X 330
Fin. 11. Atypical MCT. Malignant appearance together with polymorphism suggests a lymphoma(Hodgkin's disease, etc.). Hematoxylin-eosin; X 720.
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FIG. 12. Atypical MCT. Some areas have paucity of granules. Toluidine blue; X 720
FIG. 13. Human nodular urticaria pigmentosa. Note similarity of cells to those of typical MCT.
Hematoxylin-eosin; X 720.
I" 
464 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
and seen by the authors; also indis-
tinguishable from normal mast cells
associated with benign proliferation
(dermatitis etc.).
b. The findings in the nodular type (fig.
13) corresponded to Lever's descrip-
tion (tumor-like aggregates extending
throughout entire dermis and subcutis,
cuboidal with angular cytoplasm); cells
were strikingly similar to those of
typical MCT.
c. Eosinophils were present in quantity in
one case (nodular type).
d. Most of the mast cells of the nodular
and macular types stained heavily
with metachromatic stains.
COMMENT
The statistics in our series of cases of MCT
agree with those of the literature with the fol-
lowing exceptions: lesions were examined earlier
and were smaller, there was slight female pre-
ponderance and relatively frequent scapular in-
volvement. The series is too small for these
differences to be significant.
The eases with atypical pathology (38% of the
series) comprise 2 out of the 3 dogs with lymphad-
enopathy and all of the eases (3) with surface
ulceration and multiple lesions. They also include
the only case with an abnormal skeletal finding
and 2 of the 3 dogs in which recurrent or new
lesions developed after excision. Thus the atypi-
cal variety appears to be more malignant.
The atypical case is more difficult to diagnose
on histologic examination. In most instances a
reticulum cell lymphoma was simulated and in
one, Hodgkin's disease. The diagnosis could be
established only by using metaehromatic stains.
Nielsen and Cole (4) report that the histologic
appearances in some cases of MCT is similar to
that of Hodgkin's disease. Reports of the pathol-
ogy of Hodgkin's disease, however, are rare in the
dog (18). Tn the autopsy of a ease of urticaria
pigmentosa (Table I) Ellis (19) considered
Hodgkin's disease as a possible underlying process
where there were numerous eosinophils and
fibrosis (but no Reed-Sternberg cells). EHowever,
he found few mast cells in 10 cases of verified
Hodgkin's disease.
It would not be amiss in canine or human
medicine to examine metaehromatie stains in
eases of suspected sarcomas, unusual mesodermal
tumors and in those suspected of having a
lymphoma, particularly Hodgkin's disease, and
the reticulum cell type. Nickel suggests that a
routine stain for mast cells in the most difficult
ease may give more information than routine
connective tissue stains especially in so-called
non-specific lymphoblastoma.
The authors were unable to distinguish be-
tween the mast cell of the maeular type of
urticaria pigmentosa and the normal (or benign
hyperplastie) canine mast cell and had difficulty
distinguishing between the cell of the nodular
form of urtiearia pigmentosa and the typical
canine MCT. This is of interest but does not
necessarily imply prognostic import; since the
macule may appear in the systemic variety of
urticaria pigmentosa (20) and the nodule in the
"benign" form. Of similar interest is the striking
similarity between the 3 autopsy findings (10,
19, 21) presented in Table I. In the autopsy of
the one-year old child the two types of mast
cells described could correspond to the typical
and atypical histopathologie forms of MCT.
Ellis points out the close parallelism between the
autopsies of the one-year old girl and Bloom's
dog, emphasizing the similar cutaneous, lung,
bone marrow, liver and periadrenal involvement.
The cystic rarefaction of the isehium (ease 10)
is of great interest. Sagher and associates (22)
describe two types of bone lesions associated
with urtiearia pigmentosa: (1) general wide-
spread osteoporosis and osteoselerosis; and (2)
similar changes confined to local sites (skull,
femur, etc.). The bone changes in our ease of
MCT might be local There was no other reason
for bone involvement.
The production of a wheal after physical
stimulation of a MCT (Darier's sign) has not
been recorded. It is well accepted that release of
histamine produces the wheal in eases of urticaria
pigmentosa. Histamine is thought to be present
in MCT. Yercauteren (23) points out that horse
eosinophils contain a natural antihistamine
which can be extracted from preparations of
eosinophilic granules. He believes that eosino-
phils may detoxify histamine. The presence of
eosinophils at the site of certain allergic reactions
in both species is of interest in this regard. Riley
(24) describes an influx of eosinophils in a MCT
excised from a dog previously treated with com-
pound 48/80, a histamine liberator. Drennan (25)
describes a rapid influx of eosinophils, into a•
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lesion of urticaria pigmentosa stimulated by
trauma, cytoplasmic vacuolization and disrup-
tion with loss of metachromasia. All eases of
human urtiearia pigmentosa included in this
study urticated, despite the fact that one nodular
lesion had a large number of eosinophils. Further
study is necessary to test the thesis that eosino-
phils inhibit Darier's sign.
It is not clear whether human "malignant"
urticaria pigmentosa or the canine MCT repre-
sent a sarcoma, systemic hyperplasia, rcticulo-
endotheliosis, or systemic inflammatory process.
The finding of the mast cell in lymph nodes,
spleen, liver, bone marrow, etc. does not neces-
sarily imply metatascs in either species; since,
as Michel has pointed out, mast cells are nor-
mally present in these areas; therefore, autoch-
thonous development cannot be ruled out.
SUMMARY
A review of some facets of the mast cell and
the canine MCT is based on 13 cases studied.
Atypical histopathology in a MCT (canine
mastocytoma) implies a more malignant poten-
tial than the variety with typical histopathology.
Touch smears are useful in making a rapid
diagnosis of canine MCT. This procedure would
likely be a valuable adjunct in the diagnosis of
human urticaria pigmentosa (particularly the
nodular or tumor types).
The cystic rarefaction of the ischium observed
in one of our canine cases coincides closely to
some reported oases of bone involvement in
urticaria pigmentosa.
The inability of canine MCT to whcal on
physical trauma may be a function of the large
number of cosinophils present (antihistaminic
content).
It is suggested that metachromatic stains be
performed in canine and human sarcomas, un-
usual mesodermal tumors and lesions suspected
of being a lymphoma (particularly Hodgkin's
disease and the reticulum cell type).
The cause of canine MCT and systemic urti-
caria pigmentosa is not known. The presence of
mast cells in the viscera may not be evidence of
metastasis but may reflect an overgrowth of mass
cells present normally.
Since there is a striking similarity between the
canine mastocytoma and some cases of urticaria
pigmentosa, the canine MCT is suitable for
experimentation in relation to human urticaria
pigmentosa.
We wish to express our gratitude to Dr. Francis
W. Lynch for his guidance and advice, and to Dr.
Robert W. Goltz for considerable assistance in
interpreting the histopathologie sections.
ADDENDUM
Since the submission of this manuscript, Head
(Cutaneous Mast-Cell Tumours in the Dog,
Cat and Ox. Brit. J. Derm., 70: 389, 1958) has
published a review of mastocytoma in the dog,
cat and ox based on the study of 166 animals.
He reported 8 cases of canine mastocytoma in
which only internal organs were affected, and
offered a tentative classification of animal masto-
cytoma. Gorlin, Clark, and Chaudhry (The
Oral Pathology of Domesticated Animals. Oral
Surg., Oral Med. and Oral Path., 11: 500, 1958)
have reported one case of canine mastocytoma
originating on the hard palate and cited Riser
(Treatment of Tumors in the Dog: Comparison
of Surgery and Physiology, Proc. 91st Annual
Meeting, A.V.M.A., p. 279, 1954) as having ob-
served 3 eases in the nose and mouth.
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